UC Davis Health System
Dr. Schmidt is not a clinician. Dr. Schmidt is a molecular epidemiologist that aims to advance understanding of how early life environmental exposures interact with genetic susceptibility and molecular mechanisms to influence neurodevelopmental outcomes of children, with a primary interest in autism spectrum disorders. Her pioneering work includes highly recognized work where she found some of the first evidence in the autism field for a potentially protective effect of folic acid-rich prenatal vitamins, evidence for gene x environment interactions, and protective interactions between folate and environmental contaminants.
Dr. Schmidt leads the MARBLES high-risk autism sibling pregnancy cohort study, two wildfire pregnancy studies, a study focused on understanding the role of folate and epigenetic DNA methylation in the MARBLES and EARLI high-risk autism pregnancy cohorts, and follow-up for Northern California participants in these cohorts to assess later health outcomes in an ECHO multi-center cohort study. She additionally leads or co-leads several epidemiologic mechanistic autism studies, including examinations of mitochondrial, epigenomic, transcriptomic, and metabolomic variations as contributors to and biomarkers of neurodevelopmental outcomes.